Skip to main content
logo
Medico Remedies Limited (BOM:540937)
India flag India · Delayed Price · Currency is INR
43.68
-1.33 (-2.95%)
At close: Aug 17, 2026

Medico Remedies Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
2,3802,0641,5091,4491,4041,210
Revenue Growth
50.28%36.73%4.15%3.19%16.04%-1.12%
Gross Profit
582.9550.5407.01336.79347.51322.8
Operating Income
149.63139.32119.73100.368.9951.55
Net Income
138.15131.15100.9382.9172.4248.12
Earnings Per Share
1.661.581.221.000.870.58
EPS Growth
32.97%29.90%21.74%14.84%50.03%85.79%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
37.5137.5125.4615.4621.7723.44
Total Debt
192.04192.0414780.597.62125.97
Net Cash (Debt)
-154.53-154.53-121.54-65.05-75.85-102.53
Net Cash Growth
------
Net Cash Per Share
-1.85-1.86-1.46-0.78-0.91-1.24

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-58.7448.9224.3881.6758.62
Capital Expenditures
--44.9-31.87-24.78-65.92-59.13
Free Cash Flow
-13.8517.05-0.415.75-0.51
Free Cash Flow Growth
--18.79%----

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
24.49%26.67%26.96%23.24%24.75%26.67%
Operating Margin
6.29%6.75%7.93%6.92%4.91%4.26%
Pretax Margin
7.97%8.75%8.95%7.82%7.19%5.36%
Profit Margin
5.80%6.35%6.69%5.72%5.16%3.98%
FCF Margin
-0.67%1.13%-0.03%1.12%-0.04%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
26.3520.6542.8449.3385.6028.97
P/FCF Ratio
261.81195.64253.61-393.61-
PS Ratio
1.521.312.862.824.411.15